These fungi influence our brains by producing a compound
called psilocybin, but the origin of this chemical may have little to do with discovering fundamental truth
Not exact matches
A dozen human studies of MDMA, LSD, a powerful African drug
called ibogaine and
psilocybin, from so -
called «magic mushrooms,» are now under way, testing the once - stigmatized drugs as treatments for not only PTSD, but also cluster headaches and addiction, as well as anxiety and depression in cancer patients.
In follow - up interviews two months later, four out of five said that the
psilocybin experience had improved their well - being and satisfaction with life, about 70 percent rated the experience as among the most spiritually significant events of their lives, and nearly 70 percent
called it one of the most personally meaningful events, comparable to the birth of a first child or the death of a parent.
Coined in 1956 from the Greek root for «mind revealing,» the term psychedelic refers to a broad range of drugs that includes peyote, LSD, and
psilocybin, the primary active ingredient in so -
called magic mushrooms.
Coined in 1956 from the Greek roots for «mind revealing,» the term psychedelic refers to a broad range of drugs that include peyote, LSD, and
psilocybin, the primary active ingredient in so -
called magic mushrooms.
The new wave of research on psychedelics — «version 2.0,» as Dr. Ross
calls it — began in the early 1990s, when the Food and Drug Administration (FDA) sanctioned a few preliminary studies on
psilocybin and MDMA.
Two small studies in this special issue of the Journal of Psychopharmacology looked at the effects of
psilocybin, the active compound in what are commonly
called magic mushrooms, on patients with advanced cancer who were experiencing depression and anxiety.